Publication update – Renal cancer national SACT regimen specific consent forms

Dear All,

The consent form project team is pleased to announce that renal cell cancer SACT consent forms have been reviewed and updated. They are now available on the CRUK website at: www.cruk.org/sact_consent.

Please note we have also produced a generic consent form for tyrosine kinase inhibitor and immunotherapy, which can be used in the interim until a regimen specific form for a TKI/IO is available.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions please let me know.

Best wishes,
Alia
Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|
SACT regimen-specific consent forms: www.cruk.org/sact consent |

Latest News

By Kelly Baillie on 5th May 2024

Lets Talk About SACT – Let’s Talk About Inequalities & The British Asian Cancer Charity

The next episode of #LetsTalkAboutSact our BOPA Podcast is released on Tuesday Let’s Talk About Inequalities & The British Asian Cancer Charity is out on Tuesday 7th May We are…

Read article
By Joseph Williams on 30th April 2024

Pharmacists’ Essential Guide to Haematology – UCLH Cancer Academy

UCLH Cancer Academy would like to invite you to an educational program designed to help pharmacists’ understanding of malignant haematology. SACT-accredited pharmacists who are new to haematology or wish to…

Read article
By BOPA Committee on 30th April 2024

BOPA Passport and UTIC

Over the next few days we will rolling out an update to the current Passport content based on user feedback and errors highlighted. This includes updates to MCQs and a…

Read article
By BOPA Committee on 30th April 2024

Understanding targeted therapies and immunotherapies for cancer (UTIC)- learning course now available

ISOPP (The International Society of Oncology Pharmacy Practitioners) and BOPA (The British Oncology Pharmacy Association) are pleased to announce this joint collaboration project – UTIC (Understanding targeted therapies and immunotherapies…

Read article